Navigation Links
Hepatitis C Could Infect 800,000 Australians By 2020

It has been proposed by the federal Government to distribute subsidized life-saving hepatitis C drugs, that would benefit nearly 200,000 hepatitis C infected patients in Australia. // A small percentage of the infected individuals (2000) currently receive treatment for their condition. If appropriate steps are not instituted at the earliest, Australia might soon witness a rapid rise in the cases of liver cirrhosis and cancer.

Hepatitis C is a viral disease that is transmitted through contaminated blood. Approximately 25% get rid of the infection while the rest develop a chronic form of the disease. If left unattended, it can progress to liver cirrhosis and liver failure, eventually leading to liver cancer.

As a part of the new plan, patients would now be exempted from taking up a liver biopsy before treatment pegylated interferon can be initiated. A 45 to 90% of patients can have their hepatitis C infection eradicated if interferon therapy is instituted. Liver biopsy is associated with a small amount of risk and is usually painful. This prevents many patients from availing the diagnostic procedure and further treatment.

In addition, the lack of proper available doctors and nurses to is posing a significant challenge to curbing the Hepatitis C epidemic that has now become a public health problem. Effective management of the crisis would not be possible without increasing the number of health care professionals.

'I think this move will significantly reduce the various obstacles in the way of people with hepatitis C accessing treatment. This is a significant breakthrough in terms of trying to ensure not just that people don't get the disease, but if they get it they are treated appropriately so they lose the disease,' said Mr. Abbott, welcoming the proposal.


'"/>




Page: 1

Related medicine news :

1. Vitamin B for Hepatitis
2. Hepatitis G May Boost HIV Survival
3. Cure for Hepatitis B
4. Hepatitis E virus made impotent
5. Sharing injection equipment spreads Hepatitis C
6. Lymphomas Link to Hepatitis C
7. Hepatitis shots is promising
8. Need for Hepatitis Booster Questioned
9. Good News for HIV Patients Also Suffering From Hepatitis C Virus
10. The Link Between Hepatitis B Vaccine And Multiple Sclerosis Questioned
11. The Effectiveness Of Hepatitis B Vaccine Questioned
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the Los ... article to the newly revamped Cosmetic Town journal section, featuring articles ... procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi says ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations ... literacy software tool, and the Cancer Patient Education Network (CPEN), an independent professional ... announce a new strategic alliance. , As CPEN’s strategic partner, HLI will ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... ANN ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical ... the precise destruction of targeted tissues, announced three leadership team developments today:   ... Josh Stopek, PhD ... ... Veteran medical device executive ...
Breaking Medicine Technology: